The global Proteomics Market is estimated to be valued at Us$ 36.8 Bn in 2023 and is expected to exhibit a CAGR Of 14% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
The global Proteomics Market is estimated to be valued at Us$ 36.8 Bn in 2023 and is expected to exhibit a CAGR Of 14% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Proteomics deals with the large-scale study of proteins, particularly their structures and functions. Advances in proteomics technologies are increasingly being used for early disease detection, drug development, and personalized medicine.
Market key trends:
One of the key trends in the proteomics market is the integration of artificial intelligence and machine learning. AI is helping analyze huge proteomics data sets to discover patterns and insights. It allows researchers to identify potential drug targets, biomarkers, and gain a system-level understanding of disease pathways. AI algorithms can analyze proteomic profiles of healthy and diseased samples and identify differences indicating biomarkers or drug targets. This is streamlining the drug discovery process and pushing the boundaries of personalized medicine.
Segment Analysis
The global proteomics market is segmented by products and services, application, technology, and end user. Based on products and services, instruments dominated the market in 2023. Mass spectrometry-based instruments held the largest share as they provide high-throughput identification and characterization of proteomes. Based on application, drug discovery dominated the market in 2023 due to the increasing adoption of proteomic technologies for target identification and validation in drug development process.
Key Takeaways
The Global Proteomics Market Demand is expected to witness high growth, exhibiting CAGR of 14% over the forecast period, due to increasing research activities in omic areas such as genomics and proteomics.
Regionally, North America dominated the proteomics market in 2023. This is attributed to the presence of high-quality infrastructure for proteomics research and increasing investments in the region by government and private companies. Europe was the second largest regional market. Asia Pacific is anticipated to be the fastest-growing regional market for proteomics during the forecast period due to rising R&D spending, increasing government funding for healthcare innovations, and growing focus on clinical proteomics.
Key players operating in the proteomics market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), and Waters Corporation (US). Thermo Fisher Scientific is the market leader due to its wide product portfolio in mass spectrometry, consumables, and reagents for research and clinical applications. Danaher Corporation offers a comprehensive range of chromatography, mass spectrometry, and reagents.
Explorer more information on this topic, Please visit :
Comments
0 comment